Skip to main content
Home
Redirect
About
Management Team
Board of Directors
Publications
Publications
Investors
Investors Home
Press Releases
Events & Presentations
Events
Presentations
Stock Info
Stock Quote & Chart
Financial Information
Financial Reports
SEC Filings
Interactive Financials
Corporate Governance
Governance Documents
Committee Composition
Management Team
Board of Directors
Investor Resources
FAQs
Email Alerts & RSS Feeds
Contact Us
Contact Us
Home
Redirect
About
Management Team
Board of Directors
Publications
Publications
Investors
Investors Home
Press Releases
Events & Presentations
Events
Presentations
Stock Info
Stock Quote & Chart
Financial Information
Financial Reports
SEC Filings
Interactive Financials
Corporate Governance
Governance Documents
Committee Composition
Management Team
Board of Directors
Investor Resources
FAQs
Email Alerts & RSS Feeds
Contact Us
Contact Us
Press Releases
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2021
2020
2019
2018
2017
2015
December 18, 2020
Avenue Therapeutics Announces Publication of Tramadol Non-Medical Use in Four European Countries: A Comparative Analysis
December 18, 2020
Avenue Therapeutics Announces Publication of Real-World Data on Nonmedical Use of Tramadol in ASI-MV Network
December 17, 2020
Avenue Therapeutics Provides Regulatory Update for IV Tramadol
October 12, 2020
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
September 9, 2020
Avenue Therapeutics Announces Publication of a Review of IV Tramadol
August 14, 2020
Avenue Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
July 21, 2020
Avenue Therapeutics Announces Publication of Phase 3 Bunionectomy Study Results
June 5, 2020
Avenue Therapeutics Announces Publications in Peer-Reviewed Journals
May 29, 2020
Avenue Therapeutics to Host Virtual Annual Meeting of Stockholders
May 11, 2020
Avenue Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights
April 23, 2020
Avenue Therapeutics Announces Presentation of IV Tramadol E-Posters
March 30, 2020
Avenue Therapeutics Reports Full Year 2019 Financial Results and Recent Corporate Highlights
February 13, 2020
Avenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for Review by FDA